Vancouver, BC--(AccessWire – Aug 19, 2019) – CubicFarm® Systems Corp. (TSXV: CUB) (“CubicFarms” or the “Company”) is very pleased to announce Chris Ericson has been appointed to our board of directors.

“I am delighted to welcome Chris to our board”, stated Dave Dinesen, CEO & Director of CubicFarm® Systems Corp. “Chris is a wonderful addition to our company and helps to strengthen the existing bond with Nu Skin, which has invested in our technology in connection with its development efforts for ingredient sourcing. Chris has enjoyed a diverse business life, spanning a wide range of experiences and responsibilities in a number of countries.  As the current VP of Business Development with Nu Skin, Chris is responsible for driving long-term value for Nu Skin through the development of strategic business relationships. CubicFarms looks forward to Chris playing an active role in helping to guide and influence our growth and future development into new markets.”

Since joining Nu Skin in 2015 Ericson has led its Global Internal Audit team as VP of Internal Audit and before that served as the Director of Internal Controls.  Ericson also has more than a decade of experience in the professional services group of  PricewaterhouseCoopers (PwC), where he advised and worked closely with senior management and leadership teams of multinational, public companies.
 
Chris earned Bachelor of Science and Master of Accountancy degrees from Brigham Young University with minor degrees in Japanese and Management of Information Systems. 

“I am very excited to join the board of CubicFarms as we develop the tremendous opportunities that exist in Automated Controlled Environment Agriculture (CEA). Nu Skin and CubicFarms enjoy an excellent relationship and are working together to drive agricultural sustainability, food security and pure ingredient sourcing”, said Chris Ericson

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.